1. A randomized, double‐blind, placebo‐controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis. Issue 1 (30th April 2013) Authors: Howard, James F.; Barohn, Richard J.; Cutter, Gary R.; Freimer, Miriam; Juel, Vern C.; Mozaffar, Tahseen; Mellion, Michelle L.; Benatar, Michael G.; Farrugia, Maria Elena; Wang, Jing Jing; Malhotra, Suneil S.; Kissel, John T. Journal: Muscle & nerve Issue: Volume 48:Issue 1(2013:Jul.) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗